Uses of substantially pure interleukin-9 receptor
US5180678A · kind A · utility
14Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 1992 |
| Grant date | Jan 19, 1993 |
| Priority date | — |
| Expiry date | Feb 6, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to substantially pure interleukin 9 receptor molecules and the use thereof. The uses include use as an interleukin-9 inhibitor, as a diagnostic agent for determining interleukin-9, and as a screening agent for pharmaceuticals. The interleukin-9 receptor is characterized as a glycoprotein of about 64 kilodaltons which, upon digestion with N-glycosidase F, yields a peptide of about 54 kilodaltons.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.